Valuation: Sunrest Lifescience Limited

Market Cap 163M 1.7M 1.47M 1.39M 1.26M 2.36M 2.38M 16.59M 6.38M 82.57M 6.38M 6.24M 263M P/E 2025
11.5x
P/E 2026 3.86x
Enterprise Value 310M 3.23M 2.8M 2.65M 2.39M 4.49M 4.53M 31.57M 12.14M 157M 12.13M 11.86M 501M EV / Sales 2025
1x
EV / Sales 2026 0.43x
Free-Float
15.04%
Yield 2025 *
-
Yield 2026 -
1 day+2.29%
1 week-2.69%
Current month-4.17%
1 month-4.89%
3 months+11.95%
6 months-11.54%
Current year-8.66%
1 week 36.5
Extreme 36.5
38.9
1 month 35
Extreme 35
45
Current year 29.55
Extreme 29.55
50
1 year 29.55
Extreme 29.55
54
3 years 29.55
Extreme 29.55
84
5 years 29.55
Extreme 29.55
84
10 years 29.55
Extreme 29.55
84
Manager TitleAgeSince
Chief Executive Officer 42 2023-03-02
Director of Finance/CFO - 2023-02-28
Compliance Officer - 2026-01-15
Director TitleAgeSince
Chairman 30 2023-03-05
Director/Board Member 42 2017-10-29
Director/Board Member 44 2017-10-29
Change 5-day change 1-year change 3-year change Capi.($)
+2.29%-2.69%-14.33% - 1.66M
-0.71%+0.05%+28.66%+108.80% 105B
+0.67%-2.81%+57.22%+164.56% 54.11B
-1.89%-3.36%-13.67%+236.36% 21.66B
-0.31%-2.47%-10.87%-9.42% 8.02B
+0.27%-3.81%-38.47%-36.09% 6.84B
+0.38%-4.48%-3.33%+13.22% 6.36B
-0.40%-6.24%-20.69%-31.06% 6B
-0.21%-1.20%-4.14%+18.18% 5.02B
-9.94%-32.63%+206.06%+347.61% 3.72B
Average -0.99%-2.22%+18.64%+90.24% 21.66B
Weighted average by Cap. -0.64%-1.14%+27.96%+121.85%

Financials

2025 2026
Net sales 334M 3.48M 3.02M 2.85M 2.58M 4.85M 4.88M 34.05M 13.1M 169M 13.08M 12.79M 540M 708M 7.38M 6.4M 6.05M 5.48M 10.28M 10.35M 72.18M 27.77M 359M 27.74M 27.12M 1.15B
Net income 20.05M 209K 181K 171K 155K 291K 293K 2.04M 786K 10.17M 785K 768K 32.43M 41.16M 429K 372K 351K 318K 597K 602K 4.19M 1.61M 20.87M 1.61M 1.58M 66.56M
Net Debt 103M 1.08M 931K 881K 797K 1.5M 1.51M 10.51M 4.04M 52.29M 4.04M 3.95M 167M 147M 1.53M 1.33M 1.25M 1.14M 2.13M 2.15M 14.97M 5.76M 74.51M 5.75M 5.63M 238M
Logo Sunrest Lifescience Limited
Sunrest Lifescience Limited is an India-based pharmaceutical company. The Company is engaged in the business of selling healthcare products, medicines and cosmetics. It focuses on all healthcare segments including anti-bacterials, antibiotics, anti-amoeibics, anti- fungals, analgesic, neuropathy, anti-hypertension, anti-inflammatory, anti-ulcerants, anti-cold, anti-cough, anti-allergics, nutritionals, ayurvedic and cosmetics. The Company's product portfolio consists of a comprehensive range of tablets, capsules, soft gels, syrups, dry syrups, injections, cream ointments and powders. Its anti-diabetic products include Glimrest M1 Tablet, Glimirest PM 2 Tablet, and others. Its skincare products include Ageshine Cream 30 gm, Calorest Lotion, Clinderest Gel, and others. The Company's subsidiary is Hetvi Lifesciences Private Limited, which is engaged in the manufacturing of healthcare products. The Company operates in different states of India, such as Maharashtra and Gujarat.
Employees
-
Date Price Change Volume
26-09-15 37.95 +2.29% 8,000
26-09-15 ₹37.10 -2.50% 14,400
26-09-11 ₹38.05 +2.28% 1,600
26-09-10 ₹37.20 -5.70% 1,600
  1. Stock Market
  2. Stocks
  3. SUNREST Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!